Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

S 2266Sesión 222

Qué cambió entre versiones

45 párrafos cambiaron+541 palabras agregadas−367 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

SENATE COMMERCE COMMITTEE

STATEMENT TO

[First Reprint]

SENATE, No. 2266

with committee amendments

STATE OF NEW JERSEY

DATED: OCTOBER 5, 2026

The Senate Commerce Committee reports favorably and with committee amendments Senate Bill No. 2266.

As amended, the bill prohibits manufacturers from selling, distributing, or offering for sale or use in the State menstrual products with intentionally added PFAS. The bill defines menstrual products as those manufactured for the purpose of catching menstruation and vaginal discharge, including but not limited to a tampon, sanitary pad, disc, menstrual cup, and underwear. The term includes both disposable and reusable products.

The bill defines intentionally added PFAS as PFAS added to a product or a product's component to provide a specific characteristic, appearance, or quality or to perform a specific function and includes any degradation byproducts of PFAS. The term excludes a technically unavoidable trace quantity of PFAS as measured in organic fluorine.

The bill requires the Department of Environmental Protection (DEP) to establish a system to test for intentionally added PFAS and approve of laboratories to conduct the tests. Results of any test conducted pursuant to the bill are required to be available to the Department of Health (DOH) for inspection, either from the manufacturer or the laboratory.

A violation of the bill’s provisions would be an unlawful practice under the consumer fraud act and would be punishable by a monetary penalty of not more than $10,000 for a first offense and not more than $20,000 for any subsequent offense. Additionally, a violation of the consumer fraud act can result in cease and desist orders issued by the Attorney General, the assessment of punitive damages, and the awarding of treble damages and costs to the injured.

The bill would be effective two years after enactment, but permits the commissioners of DEP and DOH to take anticipatory administrative action.

This bill was prefiled for introduction in the 2026-2027 session pending technical review. As reported, the bill includes the changes required by technical review, which has been performed.

COMMITTEE AMENDMENTS :

The committee amended the bill to:

(1) add a definition of and references to “intentionally added PFAS;”

(2) remove the definition and references to “regulated perfluoroalkyl and polyfluoroalkyl substances;” and

(3) make a technical update.

222nd LEGISLATURE

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Senator M. TERESA RUIZ

District 29 (Essex and Hudson)

Senator LINDA R. GREENSTEIN

District 14 (Mercer and Middlesex)

Co-Sponsored by:

Senators Cryan, Diegnan, Singleton and Singer

SYNOPSIS

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

CURRENT VERSION OF TEXT

As reported by the Senate Commerce Committee on October 5, 2026, with amendments.

An Act limiting perfluoroalkyl and polyfluoroalkyl substances in menstrual products and supplementing P.L.1960, c.39 (C.56:8-1 et seq.).

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

1. a. As used in this act:

1 “Intentionally added PFAS” means PFAS added to a product or a product’s components to provide a specific characteristic, appearance, or quality or to perform a specific function. The term includes any degradation byproducts of PFAS but excludes a technically unavoidable trace quantity of PFAS as measured in total organic fluorine. 1

“Menstrual product” means a product manufactured for the purpose of catching menstruation and vaginal discharge, including but not limited to a tampon, sanitary pad, disc, menstrual cup, and underwear. The term shall include both disposable and reusable products.

“Perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” means the same as defined in subsection k. of section 1 of P.L.2023, c.243 (C.56:8-229).

1 [ “Regulated perfluoroalkyl and polyfluoroalkyl substances” or “Regulated PFAS” means:

(1) "Intentionally added PFAS," which means PFAS added to a product or one of the product's components to provide a specific characteristic, appearance, or quality or to perform a specific function and includes any degradation byproducts of PFAS; or

(2) The presence of PFAS in a product or product component above a technically unavoidable trace quantity, as measured in total organic fluorine. ] 1

b. A manufacturer of menstrual products shall not sell, distribute, or offer for sale or use in this State any menstrual product containing 1 [ regulated ] intentionally added 1 PFAS.

c. (1) The Department of Environmental Protection shall establish a system for manufacturers to periodically test for the presence of 1 [ regulated ] intentionally added 1 PFAS in menstrual products, to be conducted by a laboratory approved by the commissioner.

(2) The commissioner shall publish on the department’s Internet website a list of approved laboratories and a list of acceptable testing methods to be used to satisfy the requirements of paragraph (1) of this subsection.

d. The results of a test conducted pursuant to subsection c. of this section shall be available to the Department of Health for inspection upon request to the manufacturer or laboratory.

e. A violation of the provisions of this section shall constitute an unlawful practice for the purposes of P.L.1960, c.39 (C.56:8-1 et seq.), and the violator shall be subject to all the remedies and penalties available pursuant to P.L.1960, c.39 (C.56:8-1 et seq.).

2. This act shall take effect on the first day of the 25th month next following enactment, except that the Commissioner of Environmental Protection and the Commissioner of Health may take any anticipatory administrative action in advance as may be necessary for the implementation of this act.

Volver al texto completo